CSIMarket
 


Odonate Therapeutics Inc   (ODT)
Other Ticker:  
 
 

ODT's Revenue Growth by Quarter and Year

Odonate Therapeutics Inc 's Revenue results by quarter and year




ODT Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.22
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.22



ODT Revenue third quarter 2021 Y/Y Growth Comment
Odonate Therapeutics Inc in the third quarter 2021 recorded of $ 0.00 millions.

According to the results reported in the third quarter 2021, Odonate Therapeutics Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Odonate Therapeutics Inc ' s Revenue no change of % ranks overall at the positon no. in the third quarter 2021.




ODT Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Odonate Therapeutics Inc 's third quarter 2021 Revenue $ 0.00 millions ODT's Income Statement
Odonate Therapeutics Inc 's third quarter 2020 Revenue $ 0.00 millions Quarterly ODT's Income Statement
New: More ODT's historic Revenue Growth >>


ODT Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Odonate Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Revenue Comment


Odonate Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2021 period, Odonate Therapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Odonate Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2021 period, Odonate Therapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Odonate Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ODT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ODT's Competitors
Revenue Growth for Odonate Therapeutics Inc 's Suppliers
Revenue Growth for ODT's Customers

You may also want to know
ODT's Annual Growth Rates ODT's Profitability Ratios ODT's Asset Turnover Ratio ODT's Dividend Growth
ODT's Roe ODT's Valuation Ratios ODT's Financial Strength Ratios ODT's Dividend Payout Ratio
ODT's Roa ODT's Inventory Turnover Ratio ODT's Growth Rates ODT's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2021
Enanta Pharmaceuticals Inc-0.24%$ -0.237 millions
Zimmer Biomet Holdings Inc -0.27%$ -0.275 millions
Community Health Systems Inc -0.35%$ -0.352 millions
Quest Diagnostics Inc-0.43%$ -0.431 millions
Koru Medical Systems Inc-0.65%$ -0.654 millions
Avanos Medical Inc -0.86%$ -0.862 millions
Cytomx Therapeutics Inc -1.13%$ -1.130 millions
Bausch Health Companies Inc -1.26%$ -1.263 millions
Xtant Medical Holdings Inc -1.71%$ -1.705 millions
Mimedx Group Inc -1.91%$ -1.911 millions
Clovis Oncology inc -2.21%$ -2.208 millions
Teva Pharmaceutical Industries Limited-2.29%$ -2.288 millions
Elutia inc -2.45%$ -2.455 millions
Alimera Sciences Inc -2.57%$ -2.566 millions
Nuwellis Inc -2.68%$ -2.679 millions
Pressure Biosciences Inc -2.90%$ -2.903 millions
Lifevantage Corp-2.92%$ -2.924 millions
Immunitybio inc -2.94%$ -2.941 millions
Luna Innovations Inc-3.43%$ -3.425 millions
Cardiovascular Systems Inc -3.59%$ -3.591 millions
Vyant Bio Inc -3.95%$ -3.954 millions
Hologic Inc-4.28%$ -4.279 millions
Supernus Pharmaceuticals inc -4.30%$ -4.300 millions
Procyon Corporation-4.51%$ -4.515 millions
Healthcare Services Group Inc -4.67%$ -4.670 millions
Star Equity Holdings Inc -4.92%$ -4.922 millions
Old Ayala Inc -5.02%$ -5.015 millions
Societal Cdmo Inc -5.44%$ -5.444 millions
Inovio Pharmaceuticals Inc -6.61%$ -6.613 millions
Sangui Biotech International Inc-6.64%$ -6.640 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com